Close Menu

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Nanosphere has closed a public offering of common stock raising net proceeds of approximately $32.1 million, the firm said today.

The Northbrook, Ill.-based molecular diagnostics developer sold 15,686,000 shares of common stock at a price of $2.20 per share. Included in that share total is 2,046,000 shares issued to cover an over-allotment option.

Nanosphere said that it would use the funds for general corporate purposes and working capital.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A new blood test might be able to detect the presence of some 50 cancers, according to New Scientist.

Undark looks into how coronavirus-related shutdowns are affecting field researchers.

In PNAS this week: strategies to design DNA oligonucleotide probes for bacteria, Vibrio cholerae evolution in Haiti, and more.

NPR reports that graduate students in the US are helping with SARS-CoV-2 testing.

May
06
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.